REGENERON PHARMAC.DL-,001 financial statements, including revenue, expenses, profit, and loss

The total revenue of RGO for the last quarter is 2.91 B EUR, and it's 6.32% lower compared to the previous quarter. The net income of Q1 24 is 669.14 M EUR.